Shire PLC operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Shire PLC with three other
pharmaceutical manufacturers in Europe:
sales of 4.18 billion Euro [US$4.67 billion]
of which 100%
Novo Nordisk As
(111.78 billion Danish Kroner [US$16.81 billion]
of which 80%
was Diabetes Care), and
based in Germany
(15.02 billion Euro [US$16.81 billion]
of which 46%
During the year ended December of 2016, sales at
Shire PLC were £8.48 billion (US$10.78 billion).
increase of 101.4%
versus 2015, when the company's sales were £4.21 billion.
This was the fifth consecutive year of sales increases at Shire PLC
(and since 2011, sales have increased a total of 220%).